rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

AstraZeneca Pharma India Ltd.

506820 ASTRAZEN Group (A)

03 Jul,13:47
6400.00
33.35 (0.52%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

AstraZeneca Pharma India Ltd.

BUYSELL

568 6,366.65 6,511.00 - 6,349.60 7,208.00 - 3,650.05 16,000.00
NSE | BSE

AstraZeneca Pharma India Ltd.

ASTRAZEN

03 Jul,13:55
6406.00
42.10 (0.66%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

AstraZeneca Pharma India Ltd.

BUYSELL

13,480 6363.9 6,514.90 - 6,350.00 7,220.95 - 3,698.05 869.09

News for AstraZeneca Pharma India Ltd.

AstraZeneca...
AstraZeneca Withdraws COVID Vaccine: Surplus of Updated Vaccines
AstraZeneca is globally withdrawing its COVID-19 vaccine, Covishield, due to a surplus of newer vaccines and declining demand. The company highlights the vaccine's significant role in combating the...
May 08, 2024 14:34
AstraZeneca...
AstraZeneca Withdraws COVID-19 Vaccine: Surplus of Updated Shots
AstraZeneca has withdrawn its COVID-19 vaccine globally due to a surplus of updated vaccines. The company cites a decline in demand for Vaxzevria, which was sold as Covishield in India.
May 08, 2024 11:12
Covaxin Safe, No...
Covaxin Safe, No Side Effects: Bharat Biotech
Bharat Biotech assures Covaxin is safe and effective, with no reported side effects like blood clots, unlike Covishield. Developed with safety as priority, it was rigorously tested.
May 02, 2024 21:41
Lupin Gets USFDA...
Lupin Gets USFDA Approval for Generic Diabetes Drug
Lupin receives USFDA approval to market a generic version of AstraZeneca's Qtern tablets, a medication for type 2 diabetes. The drug will be manufactured at Lupin's Pithampur facility.
Jan 04, 2024 19:17
Lupin Gets USFDA...
Lupin Gets USFDA Approval for Generic Diabetes Drug
Lupin has received USFDA approval to market a generic medication for type 2 diabetes, a generic equivalent of AstraZeneca's Qtern tablets. The drug will be manufactured at Lupin's Pithampur facility.
Jan 04, 2024 19:12

More News for AstraZeneca Pharma India Ltd. »

(Rs. Crore)

Financial Results of AstraZeneca Pharma India Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales1,295.531,002.97805.60813.56831.81
Operating profit184.45165.1386.17135.47120.69
Interest1.200.630.951.091.14
Gross profit218.05190.5999.99147.22132.54
EPS (Rs)64.6039.7224.6437.3228.88

See more in Research Center »

News for Pharmaceuticals and health care

Sebi Notifies...
Sebi Notifies Mechanism for Brokers to Prevent Market Abuse
Sebi has mandated stock brokers to implement systems for detecting and preventing market abuse, including surveillance, reporting, and whistleblower policies. The new rules aim to curb fraudulent...
Jul 03, 2024 14:36
Federal Bank...
Federal Bank Reports 20% Loan Growth in Q1
Federal Bank's loan portfolio grew by 20% in the first quarter, with retail credit book up 25% and wholesale credit book up 14%. Deposits also rose by 20% year-on-year.
Jul 03, 2024 14:33
SECI to Float 500...
SECI to Float 500 MW Solar Thermal Tender by FY25-end
SECI plans to launch a tender for 500 MW of solar thermal capacity by FY25-end, marking the first time in India such a large-scale tender will be floated. The tender will feature advanced...
Jul 03, 2024 14:22
Premier Energies...
Premier Energies Wins 350 MW Solar Module Order
Premier Energies and its subsidiaries have secured a 350 MW solar module supply order from Apraava Energy for a project in Rajasthan, India. The modules aim to enhance efficiency and output,...
Jul 03, 2024 14:11
Areca & Coconut...
Areca & Coconut Prices in Mangaluru - July 3
Get the latest areca and coconut prices in Mangaluru for Wednesday, July 3. Check prices for old supari, new supari, koka, and different coconut qualities.
Jul 03, 2024 14:10

More News »

Top News

Sebi Notifies...
Sebi Notifies Mechanism for Brokers to Prevent Market Abuse
Sebi has mandated stock brokers to implement systems for detecting and preventing market abuse, including surveillance, reporting, and whistleblower policies. The new rules aim to curb fraudulent...
Jul 03, 2024 14:36
Federal Bank...
Federal Bank Reports 20% Loan Growth in Q1
Federal Bank's loan portfolio grew by 20% in the first quarter, with retail credit book up 25% and wholesale credit book up 14%. Deposits also rose by 20% year-on-year.
Jul 03, 2024 14:33
Guar Seed Futures Rise on Spot Demand - PTI
Guar seed futures prices rose on Wednesday, driven by firm spot market demand and thin supplies, according to market analysts. Speculators increased their positions, leading to a 0.72% increase in...
Jul 03, 2024 14:23
SECI to Float 500...
SECI to Float 500 MW Solar Thermal Tender by FY25-end
SECI plans to launch a tender for 500 MW of solar thermal capacity by FY25-end, marking the first time in India such a large-scale tender will be floated. The tender will feature advanced...
Jul 03, 2024 14:22
Koo Shuts Down:...
Koo Shuts Down: Indian Twitter Rival Bids Farewell
Indian social media platform Koo, a potential Twitter rival, is shutting down after failing to secure a partnership. The founders cite high operational costs and funding challenges.
Jul 03, 2024 14:11

More Top News »

Report Card

PE Ratios
98.85
EPS (Rs.)
64.60
Sales (Rs. Cr)
383.20
Face Value (Rs.)
2
Net Profit Margin (%)
9.89
Last Bonus
1:1
Last Dividend(%)
1200
Return on Average Equity
16.86

BSE Announcements from AstraZeneca Pharma India Ltd. (See all)

announcement Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate - 6 day(s) ago
announcement Record Date For Payment Of Final Dividend - 25 Jun 2024

Compare 'AstraZeneca Pharma India Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,517.90
  • Compare
  • Divi's Laboratories Ltd.
  • 4,599.90
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,066.95
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,351.50
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 2,779.40
  • Compare
  • Max Healthcare Institute Ltd.
  • 955.05
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,137.05
  • Compare
  • Alkem Laboratories Ltd.
  • 4,956.50
  • Compare

AstraZeneca Pharma India Ltd. performance snapshot

If you had invested Rs.  in AstraZeneca Pharma India Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Close
Add AstraZeneca Pharma India Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add AstraZeneca Pharma India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close